U.S. Markets close in 1 hr 50 mins

Better Marijuana Stock: Canopy Growth vs. Organigram Holdings

Keith Speights, The Motley Fool

As the legal medical marijuana industry in Canada has taken off, a small group of stocks of marijuana growers has vaulted to multibillion-dollar market caps. Other Canadian marijuana stocks, however, haven't become that highly valued. Canopy Growth Corporation (NASDAQOTH: TWMJF) is an example of the former group, while Organigram Holdings (NASDAQOTH: OGRMF) belongs to the latter category.

But current market cap and past performance aren't good predictors of future success. Which of these two marijuana stocks is the better pick now? Here's how Canopy Growth and Organigram compare.

Three signs, one on top of the other, with the words legal, marijuana, and cannabis on a pole with blue skies in the background

Image source: Getty Images.

The case for Canopy Growth

Canopy Growth stock has nearly tripled over the last 12 months. What's important to understand with respect to the argument for buying the stock is why that has happened. 

One reason behind Canopy Growth's tremendous performance is that the company has emerged as the leader in medical marijuana sales in Canada. In its latest quarter, Canopy reported all-time high medical marijuana revenue of 21.7 million Canadian dollars, most of which was made in its home country.

In addition to its Canadian success, Canopy Growth has established a solid international presence. The company acquired MedCann GmbH in 2016, a German medical cannabis distributor. Germany presents a significant opportunity. Canopy also has operations and/or partnerships in other international markets, including Australia, Brazil, Chile, Denmark, Jamaica, and Spain. 

Canopy Growth is the only marijuana grower so far to form a close relationship with an S&P 500 company. In October, Constellation Brands (NYSE: STZ), which markets Corona beer and other alcoholic beverages, bought a 9.9% stake in Canopy for $245 million. Constellation plans to work with Canopy to launch a cannabis-infused beer. 

Probably the biggest factor pushing Canopy Growth stock higher, though, is the anticipation of Canada legalizing recreational marijuana later in 2018. Canopy has aggressively prepared for the milestone by beefing up its production capacity and securing supply license agreements for recreational marijuana with several Canadian provinces.

These reasons for Canopy Growth's past success also reflect why to buy the stock now. The global medical marijuana market continues to grow. Canada's recreational marijuana market presents a massive opportunity. The support of a major company like Constellation Brands gives Canopy an advantage that rivals don't have. 

The case for Organigram

Organigram Holdings stock has nearly doubled over the last 12 months. Several of the catalysts for Canopy Growth have also fueled Organigram's impressive performance.

The company's medical marijuana sales in Canada are booming. In the quarter ended Nov. 30, 2017, Organigram reported revenue of CA$2.7 million, a year-over-year increase of 20%. Between January 2017 and January 2018, the company's number of medical marijuana patients jumped 495%.

Although Organigram has focused on selling in its domestic market rather than in international markets, the company hasn't closed its eyes to different kinds of opportunities outside of Canada. For example, Organigram signed an exclusive agreement with Colorado-based TGS International in 2016 to distribute The Green Solution marijuana products in Canada. 

Like Canopy Growth and other marijuana growers, Organigram is expanding its capacity in anticipation of surging demand after Canada legalizes recreational marijuana. The company will soon have annual production capacity of 36,000 kilograms. Organigram expects its capacity will increase to 113,000 kilograms annually by April 2020.

Perhaps the most compelling reason to buy Organigram stock is its valuation. No, Organigram isn't cheap right now by any stretch of the imagination. However, as my colleague Sean Williams wrote recently, the company's growth prospects could make it "the only marijuana value stock."  

Better buy

My view is that both of these stocks should generate nice gains over the next few years as Canada's recreational marijuana market opens and as the global medical marijuana market expands. However, I suspect that capacity will be king. Companies with greater capacity will probably see their stocks rise faster than those with less capacity. Because of this, I think Canopy Growth is the better choice.

Over the longer run, supply will catch up with demand. That's when retail prowess will become much more important. Canopy seems likely to have an advantage on that front also, particularly with its ties to Constellation Brands.

Investors should keep in mind, however, that buying marijuana stocks definitely come with risks. Enormous growth is already baked into the stock prices -- even for a "value marijuana stock" like Organigram. If the sizes of marijuana markets aren't as great as anticipated, both Canopy Growth and Organigram stocks could go down as fast as they've gone up. 

More From The Motley Fool

Keith Speights has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

  • What happens if you win Mega Millions' $970M jackpot?
    News
    Associated Press

    What happens if you win Mega Millions' $970M jackpot?

    Despite the terrible odds — one in 302.5 million for those keeping score at home — someone will eventually match all six numbers and win the Mega Millions jackpot, which now stands at $970 million. Here are some answers for someone holding that prized lottery ticket for what would be the second-largest lottery jackpot in U.S. history. Lottery officials recommend winners take a deep breath, put their winning ticket in a safe spot and consult with a reputable financial planner before popping over to the lottery headquarters.

  • Here's everyone who has dropped out of Saudi Arabia's 'Davos of the Middle East'
    Finance
    Yahoo Finance

    Here's everyone who has dropped out of Saudi Arabia's 'Davos of the Middle East'

    U.S. Treasury Secretary Steven Mnuchin tweeted Thursday that he will not be attending the Future Investment Initiative in Saudi Arabia next week. The news comes after prominent members of the world’s business community have been dropping out of Saudi

  • Finding a Cure for Kinder Morgan’s Frustration
    Business
    Bloomberg

    Finding a Cure for Kinder Morgan’s Frustration

    Rising profits – Ebitda was up 6 percent, year over year – and that Canadian pipeline sale have helped address Kinder Morgan’s biggest problem, its crushing debt. Thankfully, it provided a strong signal on Wednesday evening that it would.

  • The ‘smart money’ says it’s time to buy the Chinese internet giants and the U.S. FAANGs
    News
    MarketWatch

    The ‘smart money’ says it’s time to buy the Chinese internet giants and the U.S. FAANGs

    When the media and investors turn negative on stocks but the “smart money” is bullish, it’s a good time to think about buying. After all, exactly what is the smart money, and how do you know? Lately, several fund managers who pass this test have been pounding the table on Chinese internet names.

  • Business
    CNBC

    Goldman Sachs sees a correction coming for chipmakers but still likes Nvidia

    "We foresee a cyclical correction approaching and recommend investors to stay selective in Semis," Goldman Sachs said in a note Thursday. Nvidia is Goldman's top choice in the industry. Goldman Sachs warned clients about a downturn coming for the semiconductor sector, but still recommends some chip stocks.

  • Provocateur Stormy Daniels Takes an Unexpected Turn in the National Spotlight
    Politics
    Time

    Provocateur Stormy Daniels Takes an Unexpected Turn in the National Spotlight

    To understand what it means to be famous like Stormy Daniels, for the reasons she is famous, spend time with her in a public space. On Oct. 15, a California judge threw out the defamation case she filed against Donald Trump. Over the past year, Daniels, 39, has become the Zelig of White House scandals.

  • LCOR plans more multifamily in Crystal City
    Finance
    American City Business Journals

    LCOR plans more multifamily in Crystal City

    LCOR Inc. hopes to submit plans to Arlington County next month to develop a multifamily-over-retail project on part of the Verizon site in Crystal City after quietly acquiring the nearly 40,000-square-foot property over the summer. The suburban Philadelphia based developer wants to build around 280 units and up to 20,000 square feet of retail on what is now a surface lot at 400 11th St. S, excluding the Verizon switchgear facility that will remain. LCOR acquired the parcel from Verizon Communications Inc. in July for $9.5 million, according to county land records.

  • 7 Stocks Warren Buffett Can’t Stop Buying
    Finance
    InvestorPlace

    7 Stocks Warren Buffett Can’t Stop Buying

    Sometimes identifying the best stocks to buy can be difficult, but you could do a lot worse than checking out the stocks selected by one of the world’s savviest hedge fund managers — Warren Buffett. Buffett’s stock picks are a popular source for investors, and for good reason. The billionaire Buffett is many things: He’s among the world’s most successful fund managers, a legendary philanthropist and owns more than 60 companies.

  • Cramer's lightning round: For growth and yield, go with V...
    KHC
    CNBC Videos

    Cramer's lightning round: For growth and yield, go with V...

    Jim Cramer speeds through his take on callers' favorite stocks, including his favorite pick for "decent growth with good yield."

  • Aurora Cannabis Gets License for Aurora Sky Facility
    Finance
    Market Realist

    Aurora Cannabis Gets License for Aurora Sky Facility

    Key Updates from the Cannabis Sector after Legalization in Canada (Continued from Prior Part) Aurora Sky license On October 17, Aurora Cannabis (ACB) (ACBFF) announced that it received sales licenses from Health Canada. Aurora Cannabis stated that with

  • Finance
    CNBC

    China's stock market is getting pummeled and history shows that is bad news for US markets

    U.S. stocks are lower about 70 percent of the time in periods when there are big drops of 10 percent or more in Shanghai stocks, according to analytics firm Kensho. The main U.S. indexes lose about 5 percent when Shanghai stocks fall 10 percent or more in a 30-day period. Big blue chips, like Goldman and Caterpillar are among the losers, but copper and oil also fall hard when Shanghai sees a big decline.

  • Uber driver charged with kidnapping New York woman
    News
    Associated Press

    Uber driver charged with kidnapping New York woman

    An Uber driver in New York City kidnapped a woman who fell asleep in his vehicle, groped her in the back seat and then left her on the side of a highway in Connecticut, federal authorities said Tuesday. Harbir Parmar, 24, of Queens, was charged in U.S. District Court with kidnapping. "The presumption of innocence remains with my client," Parmar's lawyer, Susanne Brody, told The New York Times at the courthouse after the hearing.

  • Business
    Benzinga

    Blackstone Group Q3 Earnings Preview

    On Thursday, Blackstone Group (NYSE: BX) will release its latest earnings report. Benzinga's outlook for Blackstone Group is included in the following report. Earnings and Revenue Analysts expect Blackstone Group earnings of 75 cents per share. Revenue

  • Robinhood fires back after criticism
    SPY
    Yahoo Finance Video

    Robinhood fires back after criticism

    When Robinhood launched in 2015, it was touted as an app that allows commission-free trading for everything from stocks to ETFs to cryptocurrencies. But a report from Bloomberg says Robinhood makes more than 40 percent of its revenue from selling its data to high-frequency trading firms. Yahoo Finance's Seana Smith, Dan Roberts and Adam Shapiro talk with Robinhood co-founder Vlad Tenev.

  • Why American Airlines Group Stock Jumped 6% -- Then Gave Most of It Back
    Business
    Motley Fool

    Why American Airlines Group Stock Jumped 6% -- Then Gave Most of It Back

    Shares of American Airlines Group (NASDAQ: AAL) popped 6.4% in early trading Wednesday before retracting to close the day up less than 1% -- just 0.9%, to be precise. An upgrade assigned to the stock by Deutsche Bank appears to be the primary reason for the move. A Deutsche Bank analyst upgraded American Airlines stock from "hold" to "buy" on Wednesday, as we're told by our friends at StreetInsider.com.

  • Markets think the midterms could be as big as the presidential election
    Finance
    Yahoo Finance

    Markets think the midterms could be as big as the presidential election

    The midterm elections are less than three weeks away. According to strategists at Barclays, the options market is pricing in a 1.6% swing on election night, a modest swing given the recent volatility we’ve seen in the stock market.

  • Netflix needs lower prices to woo India
    Business
    Reuters

    Netflix needs lower prices to woo India

    MUMBAI/BENGALURU (Reuters) - Netflix Inc's (NFLX.O) Indian operation drew attention in a surge of international subscribers in the third quarter, but it faces fierce competition and a difficult cultural conundrum to make inroads with the country's more than one billion TV viewers. In a few short months, the world leader in video streaming has launched a blockbuster Mumbai-based crime thriller, been sued over comments about a former Indian Prime Minister and seen the future of two of its hit shows threatened by the #MeToo movement in India. Helped by a roster that includes top-grossing movie franchise "Baahubali", it has won fans among a young, tech savvy middle class and Chief Executive Officer Reed Hastings has said India could deliver the service's next 100 million subscribers.

  • Jamal Khashoggi's brutal death brings to question an era of Bay Area tech investment
    Finance
    American City Business Journals

    Jamal Khashoggi's brutal death brings to question an era of Bay Area tech investment

    New details have emerged about the killing of journalist Jamal Khashoggi by Saudi agents — involving his beheading and dismemberment upon entering the Saudi consulate in Istanbul, Turkey — thanks to audio files described by Turkish officials. As evidence mounts of the Washington Post columnist’s gruesome death tied to Saudi Arabia, Bay Area tech companies, which have gobbled up billions in funding from the kingdom in recent years, could see that money river dry up as Saudi investment becomes increasingly toxic. President Donald Trump has criticized those rushing to condemn the nation, telling the Associated Press: "You know, you’re guilty until proven innocent." Yet even still, Japanese investor Softbank isn’t stomaching the brutal killing tied to its major investment fund so easily.

  • Intel restructures manufacturing organization
    Finance
    American City Business Journals

    Intel restructures manufacturing organization

    Chip giant Intel is restructuring its technology and manufacturing business group as it chases more connected device markets and grapples with delays on its next chip generation. In a memo to employees, reviewed by the Business Journal, Group President and Chief Engineering Officer Murthy Renduchintala described splitting the technology and manufacturing business into three groups. The three new groups are technology development, manufacturing and operations and global supply chain.

  • Is Tilray a Better Marijuana Stock to Buy Than Aurora Cannabis?
    World
    Motley Fool

    Is Tilray a Better Marijuana Stock to Buy Than Aurora Cannabis?

    Marijuana users are cheering the legalization of marijuana for recreational use in Canada, but it's not just pot advocates who are excited. Investors are also upbeat because the recreational market for marijuana represents a massive opportunity for sales growth for leading Canadian cannabis companies, including Tilray Inc. (NASDAQ: TLRY) and Aurora Cannabis (NASDAQOTH: ACBFF). Medical marijuana has been legal in Canada for years, and while medical marijuana sales total in the hundreds of millions of dollars annually, the potential market opportunity associated with recreational use is significantly bigger.

  • Don't Fall Into These 2 Yield Traps: This Stock Is a Better Buy
    Business
    Motley Fool

    Don't Fall Into These 2 Yield Traps: This Stock Is a Better Buy

    For example, USA Compression Partners LP (NYSE: USAC) and CSI Compressco LP (NASDAQ: CCLP) offer investors yields of 12% and 13%, respectively, but they provide a niche service, and results can be volatile. Leverage can be great when things are going well, but can cause problems when times are tough.

  • The same question that can chart a path to early retirement is the one Warren Buffett used to build Berkshire Hathaway into a powerhouse
    Business
    Business Insider

    The same question that can chart a path to early retirement is the one Warren Buffett used to build Berkshire Hathaway into a powerhouse

    Inversion is a mental model that involves flipping your outlook to prevent the opposite of what you want to happen from happening. Warren Buffett and his business partner Charlie Munger employed inversion as a business strategy to build Berkshire Hathaway into a powerhouse. In a recent podcast with Brandon of the Mad Fientist, who retired early at 34, productivity expert James Clear said the same strategy Buffett used can help set someone on the path for early retirement.

  • Kinder Morgan Beats Q3 Earnings Estimates, Improves Leverage
    Finance
    Market Realist

    Kinder Morgan Beats Q3 Earnings Estimates, Improves Leverage

    Kinder Morgan Beats Q3 Earnings Estimates, Improves Leverage Kinder Morgan’s third-quarter results Kinder Morgan (KMI) announced its third-quarter results on October 17 after the markets closed. The company announced an adjusted EPS of $0.21—up ~40%

  • Pfizer Offers Early Retirement to U.S. Employees Ahead of Layoffs
    Business
    Fortune

    Pfizer Offers Early Retirement to U.S. Employees Ahead of Layoffs

    Pfizer is offering U.S. employees early retirement ahead of company cuts that will hit around 2% of its 90,000 workers worldwide, CNBC reports. In an internal message to employees Tuesday, the company said the layoffs are a part of restructuring that aims to “simplify the organization to avoid duplication, create single points of accountability and reduce the number of layers within teams,” the New York Business Journal reports. “As we prepare for growth we are creating a simpler more efficient structure which will affect some managerial roles and responsibilities,” a Pfizer spokeswoman told CBNC.

  • Alibaba (BABA) Dips More Than Broader Markets: What You Should Know
    Finance
    Zacks

    Alibaba (BABA) Dips More Than Broader Markets: What You Should Know

    Investors will be hoping for strength from BABA as it approaches its next earnings release, which is expected to be November 2, 2018. On that day, BABA is projected to report earnings of $1.16 per share, which would represent a year-over-year decline of 10.08%. Investors should also note any recent changes to analyst estimates for BABA.